Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Osmotica Pharmaceutical

Osmotica Pharmaceutical?uq=PEM9b6PF
1986 FOUNDED
PUBLIC STATUS
401-500 EMPLOYEES
OSMT STOCK SYMBOL
$7.99 SHARE PRICE (As of Friday Closing)
Description

Developer of branded and generic pharmaceutical products. The company develops both specialty and generic pharmaceutical products, neurology-based therapeutic drugs along with a portfolio of products in various stages of development focused on the treatment of movement disorders and central nervous system, using osmotic and proprietary drug delivery technology and extensive research & development, providing healthcare industry with successful commercial drugs that address the growing needs of global patient population.

Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 895 Sawyer Road
  • Marietta, GA 30062
  • United States

+1 (770) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Osmotica Pharmaceutical’s full profile, request a free trial.

Osmotica Pharmaceutical Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$6.25 - $9.20 $422M $8.04 $37.76 85.6K 52.5M

Osmotica Pharmaceutical Financials Summary

In Thousands,
USD
TTM
31-Dec-2018
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Revenue 264,000 264,000 245,749 218,460
EBITDA (10,140) (8,295)
Net Income 2,800 2,800 (45,155) (41,821)
Total Assets 885,699 978,500
Total Debt 320,686 329,025
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Osmotica Pharmaceutical Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Osmotica Pharmaceutical‘s full profile, request access.

Request full access to PitchBook

Osmotica Pharmaceutical Executive Team (4)

Name Title Board
Seat
Contact
Info
Andrew Einhorn Chief Financial Officer
Brian Markison Chief Executive Officer

2 Former Executives

You’re viewing 2 of 4 executives. Get the full list »